Depression
Conditions
Brief summary
Cognitive accounts of depression and anxiety emphasize the importance of cognitive biases in the maintenance of disorders. One specific bias is the interpretation of ambiguous information. A negative interpretation bias is defined as a systematic tendency to interpret potentially ambiguous information in a negative rather than benign way and this bias has been associated with symptoms of depression. Research has led to the recent development of computerized cognitive bias modification (CBM) techniques to augment such biases and it has been suggested that CBM techniques may be useful as an adjunct to current treatments to enhance maintenance of treatment gains and minimize relapse rates. The fact that CBM procedures lend themselves to being delivered remotely, are cost-effective, and can be self-paced in ways that suit the patient make them an ideal candidate for inclusion in the Internet-based cognitive behavioural therapy (iCBT) programs currently offered through St. Vincent's Hospital and the University of New South Wales. Therefore, the primary aim of the current trial is to evaluate the acceptability and effectiveness of adding CBM procedures to the existing iCBT modules offered through St. Vincent's Hospital and the University of New South Wales. It is expected that iCBT + CBM will result in superior treatment outcomes as indexed by a standardized clinical battery.
Interventions
OTHEROxIGen + iCBT
OxIGen is an Internet-based intervention taking place over 1 week followed by iCBT, an Internet-based treatment for depression taking place over 10 weeks.
OTHERWaitlist Control
Waitlist will receive iCBT at week 11
Sponsors
The University of New South Wales
Alishia Williams
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Meet Diagnostic and Statistical Manual of the American Psychiatric Association - 4th edition (DSM-IV) criteria for Major Depressive Disorder, * Internet access + printer access, * Australian resident, * Fluent in written and spoken English.
Exclusion criteria
* Current substance abuse/dependence, * Psychotic mental illness (Bipolar or Schizophrenia), * Current or planned psychological treatment during study duration, * Change in medication during last 1 month or intended change during study duration, * Use of Benzodiazepines, * Suicidal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in score on the Beck Depression Inventory - second edition (BDI-II). | Administered at baseline, post-intervention (1 week), and post treatment (iCBT; 11 weeks) |
Secondary
| Measure | Time frame |
|---|---|
| Change on Prospective Imagery Test (PIT). | Administered at baseline, post-intervention (1 week). |
| Change on the Kessler-10 (K10). | Administered at baseline, before each iCBT lesson, and post-treatment (week 11). |
| Change on WHO Disability Assessment Scale (WHO-DAS). | Administered baseline and post-treatment (iCBT; 11 weeks). |
| Change on the Scrambled Sentences Task (SST)- electronic version. | Administered at baseline, post-intervention (1 week). |
| Change on the State Trait Anxiety Inventory (STAI). | Administered at baseline, post intervention (week 1), and post-treatment (iCBT; 11 weeks). |
| Change on the Ambiguous Sentence Task (AST). | Administered at baseline and post-intervention (week 1). |
| Change in score on the Patient Health Questionnaire-9 (PHQ-9). | Administered at baseline, post intervention (week 1), and post treatment (week 11). |
| Change on the Repetitive Thinking Questionnaire (RTQ). | Administered at baseline, post intervention (week 1), and post-treatment (iCBT; 11 weeks). |
Countries
Australia
Outcome results
None listed